Sarvesh Chelvanambi, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| nef Gene Products, Human Immunodeficiency Virus | 3 | 2019 | 149 | 1.300 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2019 | 246 | 0.600 |
Why?
|
| Endothelial Cells | 3 | 2021 | 3589 | 0.550 |
Why?
|
| Cell Death | 1 | 2019 | 1680 | 0.430 |
Why?
|
| Hypertension, Pulmonary | 1 | 2020 | 1605 | 0.310 |
Why?
|
| HIV Infections | 5 | 2023 | 17569 | 0.260 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2019 | 3251 | 0.230 |
Why?
|
| Endogenous Retroviruses | 1 | 2023 | 112 | 0.200 |
Why?
|
| Pharmacogenetics | 1 | 2025 | 683 | 0.180 |
Why?
|
| Systems Analysis | 1 | 2021 | 168 | 0.170 |
Why?
|
| PPAR alpha | 1 | 2021 | 177 | 0.170 |
Why?
|
| Vascular Grafting | 1 | 2021 | 163 | 0.160 |
Why?
|
| Vena Cava, Inferior | 1 | 2021 | 463 | 0.150 |
Why?
|
| Jurkat Cells | 1 | 2019 | 740 | 0.140 |
Why?
|
| Macrophages | 3 | 2023 | 5802 | 0.140 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2020 | 588 | 0.140 |
Why?
|
| Drug Discovery | 1 | 2025 | 1068 | 0.140 |
Why?
|
| Endothelium | 1 | 2019 | 768 | 0.130 |
Why?
|
| NAD | 1 | 2020 | 618 | 0.130 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2021 | 1854 | 0.130 |
Why?
|
| Metabolic Diseases | 1 | 2020 | 684 | 0.110 |
Why?
|
| Lung Injury | 1 | 2018 | 433 | 0.110 |
Why?
|
| Pulmonary Emphysema | 1 | 2019 | 689 | 0.110 |
Why?
|
| Calcinosis | 1 | 2022 | 1482 | 0.110 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2018 | 1074 | 0.100 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2023 | 1551 | 0.100 |
Why?
|
| RNA-Binding Proteins | 1 | 2019 | 1891 | 0.090 |
Why?
|
| HEK293 Cells | 1 | 2019 | 4280 | 0.080 |
Why?
|
| Aortic Valve Stenosis | 1 | 2022 | 2032 | 0.080 |
Why?
|
| Cell Line | 2 | 2019 | 15602 | 0.070 |
Why?
|
| Atherosclerosis | 1 | 2023 | 3433 | 0.070 |
Why?
|
| Mice | 5 | 2023 | 82049 | 0.070 |
Why?
|
| Cells, Cultured | 2 | 2022 | 19025 | 0.070 |
Why?
|
| Gene Expression | 1 | 2020 | 7601 | 0.070 |
Why?
|
| Influenza, Human | 1 | 2018 | 1541 | 0.070 |
Why?
|
| Mice, Transgenic | 1 | 2019 | 9561 | 0.070 |
Why?
|
| Neoplasm Proteins | 1 | 2019 | 3604 | 0.070 |
Why?
|
| Phenotype | 1 | 2025 | 16726 | 0.070 |
Why?
|
| Gene Regulatory Networks | 2 | 2025 | 1752 | 0.060 |
Why?
|
| Inflammation | 2 | 2023 | 10873 | 0.060 |
Why?
|
| Cardiovascular Diseases | 3 | 2021 | 15662 | 0.060 |
Why?
|
| Cytokines | 1 | 2019 | 7452 | 0.060 |
Why?
|
| Animals | 6 | 2023 | 169285 | 0.050 |
Why?
|
| Apoptosis | 1 | 2019 | 9527 | 0.050 |
Why?
|
| Cell Line, Tumor | 1 | 2019 | 17142 | 0.050 |
Why?
|
| Biology | 1 | 2023 | 292 | 0.050 |
Why?
|
| T-Lymphocytes | 1 | 2019 | 10266 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 1 | 2018 | 9262 | 0.050 |
Why?
|
| Lung | 1 | 2019 | 10101 | 0.040 |
Why?
|
| Humans | 12 | 2025 | 768171 | 0.040 |
Why?
|
| Anti-HIV Agents | 1 | 2015 | 4573 | 0.040 |
Why?
|
| Multiple Organ Failure | 1 | 2020 | 388 | 0.040 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2022 | 835 | 0.040 |
Why?
|
| Proteomics | 2 | 2022 | 3912 | 0.040 |
Why?
|
| Exosomes | 1 | 2021 | 423 | 0.030 |
Why?
|
| Caspase 3 | 1 | 2018 | 730 | 0.030 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2018 | 760 | 0.030 |
Why?
|
| HIV | 1 | 2023 | 1597 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2019 | 65379 | 0.030 |
Why?
|
| tat Gene Products, Human Immunodeficiency Virus | 1 | 2015 | 120 | 0.030 |
Why?
|
| Injections | 1 | 2018 | 841 | 0.030 |
Why?
|
| Osteogenesis | 1 | 2022 | 1295 | 0.030 |
Why?
|
| Influenza A virus | 1 | 2018 | 460 | 0.030 |
Why?
|
| RNA | 1 | 2023 | 2722 | 0.030 |
Why?
|
| Computational Biology | 1 | 2025 | 3567 | 0.030 |
Why?
|
| Protein Transport | 1 | 2018 | 1951 | 0.030 |
Why?
|
| Aortic Valve | 1 | 2022 | 1970 | 0.020 |
Why?
|
| Graft Survival | 1 | 2021 | 3887 | 0.020 |
Why?
|
| Weight Loss | 1 | 2018 | 2721 | 0.020 |
Why?
|
| Aged | 1 | 2019 | 171502 | 0.020 |
Why?
|
| Comorbidity | 1 | 2020 | 10590 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2021 | 14488 | 0.020 |
Why?
|
| Middle Aged | 1 | 2019 | 223487 | 0.010 |
Why?
|
| Adult | 1 | 2019 | 223646 | 0.010 |
Why?
|
| HIV-1 | 1 | 2021 | 6963 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 22380 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 15949 | 0.010 |
Why?
|
| Male | 1 | 2019 | 364731 | 0.010 |
Why?
|
| Female | 1 | 2019 | 397187 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 18349 | 0.010 |
Why?
|
| Risk Factors | 1 | 2015 | 74944 | 0.000 |
Why?
|